Home Cart Sign in  
Chemical Structure| 1265965-22-7 Chemical Structure| 1265965-22-7

Structure of S49076
CAS No.: 1265965-22-7

Chemical Structure| 1265965-22-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

S49076 is a potent inhibitor of MET, AXL/MER, and FGFRs.

Synonyms: S49076

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of S49076

CAS No. :1265965-22-7
Formula : C22H22N4O4S
M.W : 438.50
SMILES Code : O=C(N1CC2=CC3=C(NC(/C3=C\C4=CC(CN5CCOCC5)=CN4)=O)C=C2)SCC1=O
Synonyms :
S49076
MDL No. :MFCD28963943
InChI Key :AREYWCZYVPSHGS-NVMNQCDNSA-N
Pubchem ID :49870909

Safety of S49076

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of S49076

RTK

Isoform Comparison

Biological Activity

Target
  • FGFR2

    FGFR2, IC50:17 nM

  • FGFR3

    FGFR3, IC50:15 nM

  • FGFR1

    FGFR1, IC50:18 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
PC9-GR4-AZD2 0.4 µM 72 hours Evaluate the antiproliferative activity of S49076 in EGFR-TKI-resistant cells, results showed PC9-GR4-AZD2 cells were sensitive to S49076 Nat Commun. 2019 Apr 18;10(1):1812
PC9-GR1-AZD3 0.2 µM 72 hours Evaluate the antiproliferative activity of S49076 in EGFR-TKI-resistant cells, results showed PC9-GR1-AZD3 cells were sensitive to S49076 Nat Commun. 2019 Apr 18;10(1):1812
PC9-GR1-AZD1 0.2 µM 72 hours Evaluate the antiproliferative activity of S49076 in EGFR-TKI-resistant cells, results showed PC9-GR1-AZD1 cells were sensitive to S49076 Nat Commun. 2019 Apr 18;10(1):1812
PC9-ER 0.3 µM 72 hours Evaluate the antiproliferative activity of S49076 in EGFR-TKI-resistant cells, results showed PC9-ER cells were sensitive to S49076 Nat Commun. 2019 Apr 18;10(1):1812
PC9-GR3 0.3 µM 72 hours Evaluate the antiproliferative activity of S49076 in EGFR-TKI-resistant cells, results showed PC9-GR3 cells were sensitive to S49076 Nat Commun. 2019 Apr 18;10(1):1812

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice PC9-ER xenograft model Oral 37.5 mg/kg/day Twice daily for 3 weeks S49076 inhibited the growth of PC9-ER xenografts in a dose-dependent manner, with a 55% reduction in tumor growth at the highest dosage of 37.5 mg/kg/day Nat Commun. 2019 Apr 18;10(1):1812
SCID female mice NSCLC xenograft model Oral 17.5 mg/kg and 35 mg/kg Twice daily for 2 weeks To evaluate the effects of S49076 alone or in combination with gefitinib on tumor growth and host body weight. Results showed that S49076 exhibited a greater anticancer effect and a greater ability in restoring sensitivity to gefitinib than the competitor capmatinib. CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1396-1411
Mice PC9-ER xenograft model Oral 37.5 mg/kg/day Twice daily for 3 weeks Evaluate the antitumor activity of S49076 in PC9-ER xenograft model, results showed a 55% reduction in tumor growth at the highest dosage Nat Commun. 2019 Apr 18;10(1):1812

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.28mL

0.46mL

0.23mL

11.40mL

2.28mL

1.14mL

22.81mL

4.56mL

2.28mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories